KC
Kevin T Conroy
President and CEO

Kevin T Conroy insider trades: Exact Sciences (EXAS) stock buys and sales

President and CEO, Exact Sciences Last trade Nov 13, 2024 156 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
85
Open-market trades
since 2005
8
Companies
last trade 2024

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Kevin reports to the SEC

and 2 more companies

Open-market buys and sales

85 trades reported on SEC Form 4, newest first

DateStockTypeValue
Nov 13, 2024EXAS↑ Buy$1.0M
May 1, 2024EXAS↓ Sell10b5-1$69K
Mar 1, 2024EXAS↓ Sell10b5-1$491K
Feb 27, 2024EXAS↓ Sell10b5-1$356K
Feb 22, 2024EXAS↓ Sell10b5-1$691K
Feb 21, 2024EXAS↓ Sell10b5-1$306K
Feb 15, 2024EXAS↓ Sell10b5-1$909K
Feb 28, 2023EXAS↓ Sell10b5-1$637K
Feb 22, 2023EXAS↓ Sell10b5-1$299K
Feb 15, 2023EXAS↓ Sell10b5-1$959K
Feb 13, 2023EXAS↓ Sell10b5-1$292K
Jul 1, 2022EXAS↓ Sell$285
Mar 1, 2022EXAS↓ Sell10b5-1$1.1M
Feb 24, 2022EXAS↓ Sell10b5-1$1.9M
Feb 23, 2022EXAS↓ Sell10b5-1$358K
Feb 15, 2022EXAS↓ Sell10b5-1$1.1M
Nov 1, 2021EXAS↓ Sell$1.6M
Oct 1, 2021EXAS↓ Sell$1.6M
Sep 1, 2021EXAS↓ Sell$2.0M
Aug 2, 2021EXAS↓ Sell$2.1M
Jul 1, 2021EXAS↓ Sell$961K
Jun 1, 2021EXAS↓ Sell10b5-1$1.4M
May 3, 2021EXAS↓ Sell10b5-1$2.5M
Apr 1, 2021EXAS↓ Sell10b5-1$3.0M
Mar 2, 2021EXAS↓ Sell10b5-1$1.4M
Mar 1, 2021EXAS↓ Sell10b5-1$4.3M
Feb 24, 2021EXAS↓ Sell10b5-1$2.2M
Feb 17, 2021EXAS↓ Sell10b5-1$2.3M
Feb 1, 2021EXAS↓ Sell10b5-1$4.2M
Jan 4, 2021EXAS↓ Sell10b5-1$4.1M
Dec 1, 2020EXAS↓ Sell10b5-1$3.8M
Nov 2, 2020EXAS↓ Sell10b5-1$4.0M
Oct 1, 2020EXAS↓ Sell10b5-1$2.8M
Sep 1, 2020EXAS↓ Sell10b5-1$1.5M
Aug 3, 2020EXAS↓ Sell10b5-1$2.4M
Feb 28, 2020EXAS↓ Sell10b5-1$782K
Feb 27, 2020EXAS↓ Sell10b5-1$1.1M
Feb 25, 2020EXAS↓ Sell10b5-1$1.5M
Mar 11, 2019EXAS↓ Sell10b5-1$979K
Feb 28, 2019EXAS↓ Sell10b5-1$933K
Feb 27, 2019EXAS↓ Sell10b5-1$872K
Feb 25, 2019EXAS↓ Sell10b5-1$1.5M
Jan 25, 2019EXAS↓ Sell10b5-1$24.7M
Nov 12, 2018EXAS↓ Sell10b5-1$11.3M
Mar 12, 2018EXAS↓ Sell10b5-1$598K
Feb 27, 2018EXAS↓ Sell10b5-1$401K
Feb 26, 2018EXAS↓ Sell10b5-1$1.1M
Feb 9, 2018EXAS↓ Sell$4.6M
Jan 23, 2018EXAS↓ Sell$5.6M
Jan 12, 2018EXAS↓ Sell$6.6M

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other EXAS insiders

Open-market trades in the last 12 months

About Kevin T Conroy's insider trades

Kevin T Conroy is President and CEO at Exact Sciences (EXAS). Since Oct 31, 2005, Kevin has reported 17 open-market purchases worth $1.4M and 68 sales worth $176.8M on SEC Form 4. There have been no open-market trades in the last 12 months.

56 sales (72% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.

Their filings also include option exercises (70 filings), grants and awards (69 filings), shares withheld for taxes (10 filings), gifts (6 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every EXAS insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.